Alignment Healthcare (NASDAQ:ALHC) Upgraded at Zacks Research

Zacks Research upgraded shares of Alignment Healthcare (NASDAQ:ALHC) from a hold rating to a strong-buy rating in a research note released on Monday morning,Zacks.com reports.

ALHC has been the topic of several other reports. Barclays raised Alignment Healthcare from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $9.00 to $13.00 in a research report on Thursday, July 31st. Stephens raised shares of Alignment Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, August 10th. Finally, KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price for the company in a research note on Monday, August 25th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $18.83.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $16.82 on Monday. The company has a market cap of $3.33 billion, a PE ratio of -60.07 and a beta of 1.18. Alignment Healthcare has a fifty-two week low of $9.15 and a fifty-two week high of $21.06. The firm has a 50-day simple moving average of $15.41 and a 200 day simple moving average of $15.67. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare’s quarterly revenue was up 49.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts anticipate that Alignment Healthcare will post -0.69 EPS for the current year.

Insider Transactions at Alignment Healthcare

In other news, CEO John E. Kao sold 355,018 shares of the stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $5,825,845.38. Following the completion of the transaction, the chief executive officer directly owned 4,533,568 shares in the company, valued at $74,395,850.88. This trade represents a 7.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, President Dawn Christine Maroney sold 215,662 shares of the business’s stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. The trade was a 10.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,388,173 shares of company stock worth $118,068,256 over the last ninety days. Insiders own 7.00% of the company’s stock.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds have recently modified their holdings of the company. MCF Advisors LLC boosted its stake in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after buying an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in Alignment Healthcare in the 1st quarter valued at about $42,000. SBI Securities Co. Ltd. lifted its holdings in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares during the last quarter. KBC Group NV bought a new position in shares of Alignment Healthcare during the 2nd quarter valued at about $44,000. Finally, Amalgamated Bank grew its stake in shares of Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after purchasing an additional 616 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.